Early Access — free while we kick the tires
EdgarHawk

ALDX Aldeyra Therapeutics, Inc. Insider Trading

Latest: President and CEO Bought $418K of Shares · Jun 2026
1 filing analyzed · Latest 2026-06-05
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
June 2026
2026-06-05
medium
Todd C Brady Buy
President and CEO
250,000 shares
$418,450
@ $1.67
Significance 5/10

CEO Todd C Brady bought 250,000 shares of ALDX at $1.67 on 2026-06-03, expanding stake to 1.72M shares; stock down -72.3% from 52-week high.

Todd C Brady, President and CEO, purchased 250,000 shares at $1.67 for a total value of $418,450.00, increasing his holdings from 1.47M to 1.72M shares. The stock currently trades at $1.71, down -72.3% from its 52-week high of $6.18, and has declined -58.6% over the past 90 days. The company reported a net loss of $-3.5M over its most recent full fiscal year and remains unprofitable. Brady's prior trade history at ALDX consists of two sells (2024-03-12 and 2024-03-11), neither of which were well-timed at the 90-day horizon, as the stock rose after both sales. This open-market purchase by the CEO occurs against a backdrop of significant stock-price erosion and persistent losses, warranting monitoring of whether additional insider activity or operational developments follow.

Get alerts for ALDX

Add ALDX to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access